Watchdog Wednesday: After The Midterms, Pharma Steps Into A Larger World
Democratic control of Congress means worries about pricing legislation and oversight hearings, but a stouter defense of regular order at FDA – assuming the drug industry can help get the user fee renewal legislation over the finish line.
